L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer
BJU International, 05/15/2012
Koutalellis G et al. – This is the first study indicating the potential of L–dopa decarboxylase gene expression as a novel prognostic biomarker in patients with prostate cancer who have undergone radical prostatectomy.



